Oncology (all articles)
Small Randomized Trial Suggests a Benefit from Metformin as Adjunctive Therapy in Patients with Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma
16 Sep, 2019 | 00:46h | UTCEffect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma: A Phase 2 Randomized Clinical Trial – JAMA Oncology (free for a limited period)
Commentary: Metformin Repurposed: Boosts Survival in TKI-Treated Lung Cancer – MedPage Today (free registration required)
Observational Study Suggests Antibiotics Can Greatly Impair the Response to Immune Checkpoint Inhibitors in Patients with Cancer
16 Sep, 2019 | 00:48h | UTCAssociation of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer – JAMA Oncology (free for a limited period)
Author Interview: Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer (free audio)
Commentaries: Antibiotics reduce survival rates in cancer patients taking immunotherapy – Imperial College London (free) AND Antibiotics prior to immunotherapy lower survival rate for cancer patients, study says – UPI (free)
Related Commentary on Twitter
https://twitter.com/EricTopol/status/1172514038330212357
European Guidelines on Endoscopic Management of Polyposis Syndromes
15 Sep, 2019 | 23:58h | UTC
[Abstract Only] Study: Liquid vs. Tissue Biopsy for Detecting Acquired Resistance and Tumor Heterogeneity in Gastrointestinal Cancers
15 Sep, 2019 | 23:41h | UTCLiquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers – Nature Medicine (link to abstract – $ for full-text)
Commentary: Liquid biopsies reveal genetic alterations linked to cancer drug resistance – Broad Institute of MIT and Harvard (free)
Related Commentary on Twitter
6 words not often seen in top tier journals: "These findings have profound therapeutic implications …and highlight the potential advantages of cfDNA [liquid biopsy] over tissue biopsy in the setting of acquired [#cancer] resistance.https://t.co/92gF4OX10H @NatureMedicine pic.twitter.com/mj0NQC17SP
— Eric Topol (@EricTopol) September 10, 2019
Study: Progress in Cancer Survival, Mortality, and Incidence in Seven High-income Countries 1995–2014
15 Sep, 2019 | 23:35h | UTCCommentaries: Cancer Patients in Rich Countries Are Gaining Years, Study Shows – Bloomberg (free) AND Cancer survival in high income countries is improving but international disparities persist – eCancer News (free)
Related Commentary on Twitter
1-yr & 5-yr survival of seven #cancers (oesophagus, stomach, colon, rectum, pancreas, lung & ovary) improved in Australia, Canada, Denmark, Ireland, New Zealand, Norway & UK: SURVMARK-2 study of 3.9m cancer cases 1995-2014 @IARCWHO https://t.co/NqWmKl5T6R pic.twitter.com/xhmIpCwflq
— The Lancet Oncology (@TheLancetOncol) September 11, 2019
Study: Off-target Toxicity is a Common Mechanism of Action of Cancer Drugs Undergoing Clinical Trials
13 Sep, 2019 | 08:19h | UTCOff-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials – Science Translational Medicine (free for a limited period)
Commentaries: Cancer drugs don’t always work as intended, researchers warn – Cold Spring Harbor Laboratory (free) AND Why Aren’t Cancer Drugs Better? The Targets Might Be Wrong – The New York Times (10 articles per month are free)
[Abstract Only] Study: Older Women with comorbidities Have Little Benefit from Mammography Screening
12 Sep, 2019 | 08:42h | UTCScreening mammography outcomes: risk of breast cancer and mortality by comorbidity score and age – JNCI: Journal of the National Cancer Institute (link to abstract – $ for full-text)
Commentaries: More evidence screening mammograms not needed for many older women – Reuters (free) AND Mammography unlikely to benefit older women with chronic illnesses – Georgetown University Medical Center (free)
Randomized Trial: Effects of Helicobacter pylori Treatment and Vitamin and Garlic Supplementation on Gastric Cancer Incidence and Mortality
12 Sep, 2019 | 08:09h | UTC
Related Commentary on Twitter
Treating Helicobacter pylori with antibiotics for two weeks and taking vitamin or garlic supplements for just over seven years may be linked to a lower risk of developing stomach cancer in those at high risk, finds new research https://t.co/Jq7SBTdDAO
— The BMJ (@bmj_latest) September 12, 2019
ASTRO Guideline: Radiation Therapy for Pancreatic Cancer
12 Sep, 2019 | 08:01h | UTCCommentaries: ASTRO Guideline on Use of Radiation Therapy for Patients With Pancreatic Cancer – The ASCO Post (free) AND New guideline clarifies role of radiation therapy in pancreatic cancer treatment – American Society for Radiation Oncology (free)
[Abstract Only] Observational Study: Men with Prostate Cancer and Pre-existing CV Comorbidities Have Increased Mortality Risk Following Oral Antiandrogen Therapy
12 Sep, 2019 | 07:53h | UTCMortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities – European Urology (link to abstract – $ for full-text)
Commentaries: CVD Prior to Oral Antiandrogen Therapy for Prostate Cancer Increases Mortality Risk – Cancer Therapy Advisor (free) AND Risks of Novel Oral Prostate Cancer Therapies and Pre-existing Conditions – Thomas Jefferson University (free)
Systematic Review: Follow‐up Strategies for Patients Treated for Non‐metastatic Colorectal Cancer
11 Sep, 2019 | 00:03h | UTCFollow‐up strategies for patients treated for non‐metastatic colorectal cancer – Cochrane Library (free)
Summary: Follow-up strategies for participants treated for non-metastatic colorectal cancer – Cochrane Library (free)
NCCN Guideline: Small Bowel Adenocarcinoma
10 Sep, 2019 | 01:18h | UTC
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment of Colorectal Cancer
10 Sep, 2019 | 01:19h | UTC
[Abstract Only] Randomized Trial: Adjuvant Radiotherapy Following Radical Prostatectomy vs. Radical Prostatectomy Alone in Prostate Cancer Patients with Positive Margins or Extracapsular Extension
10 Sep, 2019 | 00:56h | UTCRandomised Trial of Adjuvant Radiotherapy Following Radical Prostatectomy Versus Radical Prostatectomy Alone in Prostate Cancer Patients with Positive Margins or Extracapsular Extension – European Urology (link to abstract – $ for full-text)
Commentaries: Adjuvant Radiotherapy After Radical Prostatectomy vs Radical Prostatectomy Alone in Patients With Positive Margins or Extracapsular Extension – The ASCO Post (free) AND Adjuvant radiotherapy may be beneficial in treating locally advanced prostate cancer – University of Helsinki (free)
Source: EvidenceAlerts
[Abstract Only] Another Study Points to Increased Colorectal Cancer Incidence in Young Adults
8 Sep, 2019 | 23:05h | UTCGlobal patterns and trends in colorectal cancer incidence in young adults – Gut (link to abstract – $ for full-text)
Commentaries: Global analysis finds early onset colorectal cancer rising in many high-income countries – American Cancer Society (free) AND Increase in CRC in Young Adults in Many High-Income Countries – Medscape (free registration required)
Related: More Colon Cancer Cases are Being Diagnosed in People Under 50 (link to abstract and commentaries)
Systematic Review: Hypofractionation (Fewer, Larger Doses of Daily Radiation) for Clinically Localized Prostate Cancer Results in Similar Oncologic Outcomes
8 Sep, 2019 | 23:00h | UTCHypofractionation for clinically localized prostate cancer – Cochrane Library (free)
Systematic Review: Taxanes for Adjuvant Treatment of Early Breast Cancer
8 Sep, 2019 | 22:59h | UTCTaxanes for adjuvant treatment of early breast cancer – Cochrane Library (free)
Summary: Taxane-containing chemotherapy for women after surgery for early breast cancer – Cochrane Library (free)
Population-based Cohort Study: Exposure to Diagnostic Low-Dose Ionizing Radiation Associated with Increased Risk for Many Types of Cancers
5 Sep, 2019 | 08:27h | UTC
ASCO Guideline: Use of Endocrine Therapy for Breast Cancer Risk Reduction
5 Sep, 2019 | 08:15h | UTCRelated: USPSTF Recommendation Statement: Medication Use to Reduce Risk of Breast Cancer (free)
USPSTF Recommendation Statement: Medication Use to Reduce Risk of Breast Cancer
4 Sep, 2019 | 09:11h | UTCRecommendation Summary: Medication Use to Reduce Risk of Breast Cancer (free)
Editorials: Medications to Reduce Breast Cancer Risk: Promise and Limitations (free for a limited period) AND Breast Cancer Chemoprevention—Can We Make a Case for Precision Medicine? (free for a limited period)
Evidence Report and Systematic Review: Medication Use for the Risk Reduction of Primary Breast Cancer in Women – US Preventive Services Task Force (free)
Author Interview: USPSTF Recommendation: Medication Use to Reduce Risk of Breast Cancer (free audio)
Commentaries: Medication can lower some women’s risk of breast cancer – Reuters (free) AND USPSTF: Aromatase Inhibitors Recommended to Help Prevent Breast Cancer – NEJM Journal Watch (free)
#ESCCongress – Study: Cancer Now Leading Cause of Death in High-income Countries
4 Sep, 2019 | 09:32h | UTCVariations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study – The Lancet (free for a limited period – registration required)
Related Study: Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study – The Lancet (free for a limited period – registration required)
Commentaries: Cancer now leading cause of death in high-income countries — while heart disease burden persists in low-income and middle-income countries – The Lancet (free) AND Cardiovascular Disease Leading Cause of Death World-Wide, but Cancer Rising Cause in Rich Countries: Study – McMaster University (free) AND Cancer ‘biggest middle-age killer in rich nations’ – BBC (free) AND Cancer overtakes heart disease as biggest rich-world killer – Reuters (free) AND Cancer now tops heart disease as the No. 1 cause of death in these countries – CNN (free)
Related Commentary on Twitter
Presenting now #ESCCongress—#CVD remains leading cause of mortality globally, accounting for 40% of deaths, but in HIC, #cancer is now responsible for twice as many deaths: findings from #PUREStudy
Free to read with reg until Sept 10 #LancetCardiology https://t.co/iXSfIio77D pic.twitter.com/eHEJ0kWWfa
— The Lancet (@TheLancet) September 3, 2019
Meta-Analysis: Menopausal Hormone Therapy Increases Breast Cancer Risk
30 Aug, 2019 | 08:55h | UTCCommentaries: Menopausal hormones: definitive evidence for breast cancer – The Lancet (free) AND Menopausal hormone therapy and 20-year breast cancer mortality – The Lancet (free) AND Hormone therapy during menopause raises breast cancer risk for years, study finds – STAT (free) AND Expert reaction to study looking at HRT use and risk of breast cancer – Science Media Centre (free)
Cardiovascular Toxicity of Immune Checkpoint Inhibitors in Cancer Patients
28 Aug, 2019 | 02:11h | UTCRelated: Immune Checkpoint Inhibitor Toxicities (free guidelines and reviews on the subject)
Meta-Analysis: Cardiovascular Adverse Events Associated With BRAF and MEK Inhibitors for the Treatment of Melanoma
28 Aug, 2019 | 02:11h | UTCCommentary: Risk of Cardiovascular Adverse Events in Patients With Melanoma Treated With Combined BRAF and MEK Inhibition vs BRAF Inhibition Alone – The ASCO Post (free)
Review: Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer
28 Aug, 2019 | 02:06h | UTCSystemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer: A Review – JAMA (free for a limited period)


